Locke Lord advised Chicago Pacific Founders on the deal. P3 Health Partners Inc. (Nasdaq: PIII), a patient-centered and physician-led population health management company (the “Company”), announced...
P3 Health Partners’ $90 Million PIPE Offering
Lime Rock New Energy’s Investment in Aperia Technologies
Locke Lord advised Lime Rock New Energy on the deal. Lime Rock New Energy announced an investment in Aperia Technologies Inc., the leading supplier of tire...
Prospect Partners’ Investment in Fontanesi & Kann and Architectural Building Components
Locke Lord advised Prospect Partners on the deal. Prospect Partners announced the investment in affiliated companies Fontanesi & Kann, an HVAC equipment and servicing company, and Architectural...
Amberdata’s Acquisition of Genesis Volatility
Locke Lord advised Genesis Volatility on the deal. Amberdata, the leading provider of digital asset data, announced its acquisition of Genesis Volatility (GVol), a provider of institutional-grade...
LGC’s Acquisition of Rapid Genomics
Locke Lord advised Rapid Genomics on the deal. Rapid Genomics, a provider of mid-to high-density Next-Generation Sequencing kits and services for genotyping, announced its sale to LGC,...